Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 9/20 | 0.46 |
| ▸ | CA2 | P00918 | 9/20 | 0.46 |
| ▸ | CA9 | Q16790 | 8/20 | 0.46 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | CA3 | P07451 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 2/20 | 0.46 |
| ▸ | CA5A | P35218 | 2/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3616789 | 1.00 | HPGD (0.50) | HPGDALDH1A1KMT2ACA1CA2 | |
| SCHEMBL15543392 | 1.00 | HPGD (0.50) | HPGDALDH1A1KMT2ACA1CA2 | |
| SCHEMBL28331275 | 1.00 | HPGD (0.50) | HPGDALDH1A1KMT2ACA1CA2 | |
| SCHEMBL7787201 | 1.00 | HPGD (0.50) | HPGDALDH1A1KMT2ACA1CA2 | |
| SCHEMBL7783839 | 1.00 | HPGD (0.50) | HPGDALDH1A1KMT2ACA1CA2 | |
| SCHEMBL7784180 | 1.00 | HPGD (0.50) | HPGDALDH1A1KMT2ACA1CA2 | |
| SCHEMBL7784231 | 1.00 | HPGD (0.50) | HPGDALDH1A1KMT2ACA1CA2 | |
| SCHEMBL3140142 | 1.00 | HPGD (0.50) | HPGDALDH1A1KMT2ACA1CA2 | |
| SCHEMBL2230470 | 1.00 | HPGD (0.50) | HPGDALDH1A1KMT2ACA1CA2 | |
| SCHEMBL232203 | 0.98 | HPGD (0.49) | HPGDALDH1A1KMT2ACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1620 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146335-A1 | STRAY CURRENT CORROSION INHIBITOR | CHAMPIONX LLC (US) | 2026-05-28 | — | — | US | claimed |
| US-12590017-B2 | Zero liquid discharge water management system | SAUDI ARABIAN OIL COMPANY (SA) | 2026-03-31 | — | — | US | claimed |
| US-20250305152-A1 | COMPOSITION, ITS USE AND A PROCESS FOR CLEANING SUBSTRATES COMPRISING COBALT AND COPPER | BASF SE (DE) | 2025-10-02 | — | — | US | claimed |
| EP-4577614-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING THE SAME | ChampionX LLC (US) | 2025-07-02 | — | — | EP | claimed |
| EP-4532647-A1 | COMPOSITION, ITS USE AND A PROCESS FOR CLEANING SUBSTRATES COMPRISING COBALT AND COPPER | BASF SE (DE) | 2025-04-09 | — | — | EP | claimed |
| US-20240217844-A1 | ZERO LIQUID DISCHARGE WATER MANAGEMENT SYSTEM | SAUDI ARABIAN OIL COMPANY (SA) | 2024-07-04 | — | — | US | claimed |
| EP-4347744-A1 | COMPOSITIONS AND METHODS FOR SELECTIVELY ETCHING SILICON NITRIDE FILMS | Entegris, Inc. (US) | 2024-04-10 | — | — | EP | claimed |
| US-20240093090-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING THE SAME | CHAMPIONX USA INC. (US) | 2024-03-21 | — | — | US | claimed |
| WO-2024044107-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING THE SAME | CHAMPIONX LLC (US) | 2024-02-29 | — | — | WO | claimed |
| US-20240044016-A1 | COMPOSITIONS AND METHODS FOR METAL WEAR LOSS INHIBITION | CHAMPIONX LLC | 2024-02-08 | — | — | US | claimed |
| US-5858927-A | WAX DISPERSANT AND ORGANIC CRYSTAL MODIFIER COMPOSITION DISPERSED THROUGH CONTINUOUS WATER PHASE; LOW VISCOSITY CRYSTALLIZATION INHIBITOR FOR PETROLEUM LIQUIDS | BAKER HUGHES, INCORPORATED (US) | 1999-01-12 | — | — | US | claimed |
| WO-1998009056-A1 | AQUEOUS EXTERNAL CRYSTAL MODIFIER DISPERSION | PETROLITE CORPORATION (US) | 1998-03-05 | — | — | WO | claimed |
| US-5641841-A | POLYANILINE DERIVATIVE MADE SOLUBLE WITH LONG CHAIN ORGANIC ACID OR HYDROCARBON SIDE CHAIN | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1997-06-24 | — | — | US | claimed |
| EP-0453677-B1 | Depression of the flotation of silica or siliceous gangue in mineral flotation | DOW CHEMICAL CO (US) | 1995-08-09 | — | — | EP | claimed |
| US-5126062-A | Calcium sulfonate grease and method of manufacture | NCH CORPORATION (US) | 1992-06-30 | — | — | US | claimed |
| US-5125976-A | Wetting agent | CESKOSLOVENSKA AKADEMIE VED (CS) | 1992-06-30 | — | — | US | claimed |
| US-5076851-A | Synthetic surface active matter, and granulated blast furnace slag and-or ash | CESKOSLOVENSKA AKADEMIE VED (CS) | 1991-12-31 | — | — | US | claimed |
| CN-1056445-A | The method that suppresses silica or siliceous gangue flotation in the mineral floating process | DOW CHEMICAL CO (US) | 1991-11-27 | — | — | CN | claimed |
| EP-0453677-A1 | Depression of the flotation of silica or siliceous gangue in mineral flotation | THE DOW CHEMICAL COMPANY (US) | 1991-10-30 | — | — | EP | claimed |
| US-5057209-A | Adding alkanolamine | THE DOW CHEMICAL COMPANY (US) | 1991-10-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146335-A1 | STRAY CURRENT CORROSION INHIBITOR | SMOX, TST, SMS | HPGD 3979/4885ALDH1A1 1788/4885KMT2A 2924/4885 |
| US-12590017-B2 | Zero liquid discharge water management system | SHH, DEGS1, HCN1 | HPGD 1164/4885ALDH1A1 4712/4885KMT2A 4779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.